Global Marine Derived Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Most marine-derived compounds possess a few defining characteristics. First, often very low doses are given to patients, and they are administered almost exclusively via intravenous infusion (i.v.). The compounds are typically large molecules, especially the depsipeptides, and they are often hydrophobic. These attributes make them fascinating compounds in terms of pharmacokinetics but also from a bioanalytical point of view.
The first marine-derived compound approved by the United States (US) Food and Drug Administration (FDA) was cytarabine (Cytosar U®) in 1969, followed by trabectedin (Yondelis®),eribulin mesylate (Halaven®), brentuximab vedotin (Adcetris®), and midostaurin (Rydapt®) in the years 2007, 2010, 2011, 2013, and 2017, respectively.
According to our (Global Info Research) latest study, the global Marine Derived Drugs market size was valued at US$ 2641 million in 2023 and is forecast to a readjusted size of USD 4674 million by 2030 with a CAGR of 8.6% during review period.
Global Marine Derived Drugs key players include Seattle Genetics, Eisai Co, Tekada, Pfizer, Pharma Mar, etc. Global top five manufacturers hold a share about 85%.
North America is the largest market, with a share about 50%, followed by Europe and China, both have a share over 30 percent.
In terms of product, Mollusk is the largest segment, with a share about 50%. And in terms of application, the largest application is Antitumor Drugs, followed by Anti-Cardiovascular Drugs.
This report is a detailed and comprehensive analysis for global Marine Derived Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Marine Derived Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030
Global Marine Derived Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030
Global Marine Derived Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030
Global Marine Derived Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Marine Derived Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Marine Derived Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Seattle Genetics, Eisai Co, Tekada, Pfizer, Pharma Mar, Johnson and Johnson, GSK, TerSera Therapeutics, Teva, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Marine Derived Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Marine Derived Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Marine Derived Drugs, with price, sales quantity, revenue, and global market share of Marine Derived Drugs from 2019 to 2024.
Chapter 3, the Marine Derived Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Marine Derived Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Marine Derived Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Marine Derived Drugs.
Chapter 14 and 15, to describe Marine Derived Drugs sales channel, distributors, customers, research findings and conclusion.
The first marine-derived compound approved by the United States (US) Food and Drug Administration (FDA) was cytarabine (Cytosar U®) in 1969, followed by trabectedin (Yondelis®),eribulin mesylate (Halaven®), brentuximab vedotin (Adcetris®), and midostaurin (Rydapt®) in the years 2007, 2010, 2011, 2013, and 2017, respectively.
According to our (Global Info Research) latest study, the global Marine Derived Drugs market size was valued at US$ 2641 million in 2023 and is forecast to a readjusted size of USD 4674 million by 2030 with a CAGR of 8.6% during review period.
Global Marine Derived Drugs key players include Seattle Genetics, Eisai Co, Tekada, Pfizer, Pharma Mar, etc. Global top five manufacturers hold a share about 85%.
North America is the largest market, with a share about 50%, followed by Europe and China, both have a share over 30 percent.
In terms of product, Mollusk is the largest segment, with a share about 50%. And in terms of application, the largest application is Antitumor Drugs, followed by Anti-Cardiovascular Drugs.
This report is a detailed and comprehensive analysis for global Marine Derived Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Marine Derived Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030
Global Marine Derived Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030
Global Marine Derived Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030
Global Marine Derived Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Marine Derived Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Marine Derived Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Seattle Genetics, Eisai Co, Tekada, Pfizer, Pharma Mar, Johnson and Johnson, GSK, TerSera Therapeutics, Teva, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Marine Derived Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Mollusk
- Sponge
- Tunicate
- Fish
- Others
- Antitumor Drugs
- Anti-Cardiovascular Drugs
- Others
- Seattle Genetics
- Eisai Co
- Tekada
- Pfizer
- Pharma Mar
- Johnson and Johnson
- GSK
- TerSera Therapeutics
- Teva
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Marine Derived Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Marine Derived Drugs, with price, sales quantity, revenue, and global market share of Marine Derived Drugs from 2019 to 2024.
Chapter 3, the Marine Derived Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Marine Derived Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Marine Derived Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Marine Derived Drugs.
Chapter 14 and 15, to describe Marine Derived Drugs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Marine Derived Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Mollusk
1.3.3 Sponge
1.3.4 Tunicate
1.3.5 Fish
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Marine Derived Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Antitumor Drugs
1.4.3 Anti-Cardiovascular Drugs
1.4.4 Others
1.5 Global Marine Derived Drugs Market Size & Forecast
1.5.1 Global Marine Derived Drugs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Marine Derived Drugs Sales Quantity (2019-2030)
1.5.3 Global Marine Derived Drugs Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Seattle Genetics
2.1.1 Seattle Genetics Details
2.1.2 Seattle Genetics Major Business
2.1.3 Seattle Genetics Marine Derived Drugs Product and Services
2.1.4 Seattle Genetics Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Seattle Genetics Recent Developments/Updates
2.2 Eisai Co
2.2.1 Eisai Co Details
2.2.2 Eisai Co Major Business
2.2.3 Eisai Co Marine Derived Drugs Product and Services
2.2.4 Eisai Co Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Eisai Co Recent Developments/Updates
2.3 Tekada
2.3.1 Tekada Details
2.3.2 Tekada Major Business
2.3.3 Tekada Marine Derived Drugs Product and Services
2.3.4 Tekada Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Tekada Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Marine Derived Drugs Product and Services
2.4.4 Pfizer Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Pfizer Recent Developments/Updates
2.5 Pharma Mar
2.5.1 Pharma Mar Details
2.5.2 Pharma Mar Major Business
2.5.3 Pharma Mar Marine Derived Drugs Product and Services
2.5.4 Pharma Mar Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Pharma Mar Recent Developments/Updates
2.6 Johnson and Johnson
2.6.1 Johnson and Johnson Details
2.6.2 Johnson and Johnson Major Business
2.6.3 Johnson and Johnson Marine Derived Drugs Product and Services
2.6.4 Johnson and Johnson Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Johnson and Johnson Recent Developments/Updates
2.7 GSK
2.7.1 GSK Details
2.7.2 GSK Major Business
2.7.3 GSK Marine Derived Drugs Product and Services
2.7.4 GSK Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 GSK Recent Developments/Updates
2.8 TerSera Therapeutics
2.8.1 TerSera Therapeutics Details
2.8.2 TerSera Therapeutics Major Business
2.8.3 TerSera Therapeutics Marine Derived Drugs Product and Services
2.8.4 TerSera Therapeutics Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 TerSera Therapeutics Recent Developments/Updates
2.9 Teva
2.9.1 Teva Details
2.9.2 Teva Major Business
2.9.3 Teva Marine Derived Drugs Product and Services
2.9.4 Teva Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Teva Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MARINE DERIVED DRUGS BY MANUFACTURER
3.1 Global Marine Derived Drugs Sales Quantity by Manufacturer (2019-2024)
3.2 Global Marine Derived Drugs Revenue by Manufacturer (2019-2024)
3.3 Global Marine Derived Drugs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Marine Derived Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Marine Derived Drugs Manufacturer Market Share in 2023
3.4.3 Top 6 Marine Derived Drugs Manufacturer Market Share in 2023
3.5 Marine Derived Drugs Market: Overall Company Footprint Analysis
3.5.1 Marine Derived Drugs Market: Region Footprint
3.5.2 Marine Derived Drugs Market: Company Product Type Footprint
3.5.3 Marine Derived Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Marine Derived Drugs Market Size by Region
4.1.1 Global Marine Derived Drugs Sales Quantity by Region (2019-2030)
4.1.2 Global Marine Derived Drugs Consumption Value by Region (2019-2030)
4.1.3 Global Marine Derived Drugs Average Price by Region (2019-2030)
4.2 North America Marine Derived Drugs Consumption Value (2019-2030)
4.3 Europe Marine Derived Drugs Consumption Value (2019-2030)
4.4 Asia-Pacific Marine Derived Drugs Consumption Value (2019-2030)
4.5 South America Marine Derived Drugs Consumption Value (2019-2030)
4.6 Middle East & Africa Marine Derived Drugs Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Marine Derived Drugs Sales Quantity by Type (2019-2030)
5.2 Global Marine Derived Drugs Consumption Value by Type (2019-2030)
5.3 Global Marine Derived Drugs Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Marine Derived Drugs Sales Quantity by Application (2019-2030)
6.2 Global Marine Derived Drugs Consumption Value by Application (2019-2030)
6.3 Global Marine Derived Drugs Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Marine Derived Drugs Sales Quantity by Type (2019-2030)
7.2 North America Marine Derived Drugs Sales Quantity by Application (2019-2030)
7.3 North America Marine Derived Drugs Market Size by Country
7.3.1 North America Marine Derived Drugs Sales Quantity by Country (2019-2030)
7.3.2 North America Marine Derived Drugs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Marine Derived Drugs Sales Quantity by Type (2019-2030)
8.2 Europe Marine Derived Drugs Sales Quantity by Application (2019-2030)
8.3 Europe Marine Derived Drugs Market Size by Country
8.3.1 Europe Marine Derived Drugs Sales Quantity by Country (2019-2030)
8.3.2 Europe Marine Derived Drugs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Marine Derived Drugs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Marine Derived Drugs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Marine Derived Drugs Market Size by Region
9.3.1 Asia-Pacific Marine Derived Drugs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Marine Derived Drugs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 South Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Marine Derived Drugs Sales Quantity by Type (2019-2030)
10.2 South America Marine Derived Drugs Sales Quantity by Application (2019-2030)
10.3 South America Marine Derived Drugs Market Size by Country
10.3.1 South America Marine Derived Drugs Sales Quantity by Country (2019-2030)
10.3.2 South America Marine Derived Drugs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Marine Derived Drugs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Marine Derived Drugs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Marine Derived Drugs Market Size by Country
11.3.1 Middle East & Africa Marine Derived Drugs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Marine Derived Drugs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Marine Derived Drugs Market Drivers
12.2 Marine Derived Drugs Market Restraints
12.3 Marine Derived Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Marine Derived Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Marine Derived Drugs
13.3 Marine Derived Drugs Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Marine Derived Drugs Typical Distributors
14.3 Marine Derived Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OFTABLES
Table 1. Global Marine Derived Drugs Consumption Value byType, (USD Million), 2019 & 2023 & 2030
Table 2. Global Marine Derived Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Seattle Genetics Basic Information, Manufacturing Base and Competitors
Table 4. Seattle Genetics Major Business
Table 5. Seattle Genetics Marine Derived Drugs Product and Services
Table 6. Seattle Genetics Marine Derived Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Seattle Genetics Recent Developments/Updates
Table 8. Eisai Co Basic Information, Manufacturing Base and Competitors
Table 9. Eisai Co Major Business
Table 10. Eisai Co Marine Derived Drugs Product and Services
Table 11. Eisai Co Marine Derived Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Eisai Co Recent Developments/Updates
Table 13.Tekada Basic Information, Manufacturing Base and Competitors
Table 14.Tekada Major Business
Table 15.Tekada Marine Derived Drugs Product and Services
Table 16.Tekada Marine Derived Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17.Tekada Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Marine Derived Drugs Product and Services
Table 21. Pfizer Marine Derived Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Pfizer Recent Developments/Updates
Table 23. Pharma Mar Basic Information, Manufacturing Base and Competitors
Table 24. Pharma Mar Major Business
Table 25. Pharma Mar Marine Derived Drugs Product and Services
Table 26. Pharma Mar Marine Derived Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Pharma Mar Recent Developments/Updates
Table 28. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 29. Johnson and Johnson Major Business
Table 30. Johnson and Johnson Marine Derived Drugs Product and Services
Table 31. Johnson and Johnson Marine Derived Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Johnson and Johnson Recent Developments/Updates
Table 33. GSK Basic Information, Manufacturing Base and Competitors
Table 34. GSK Major Business
Table 35. GSK Marine Derived Drugs Product and Services
Table 36. GSK Marine Derived Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. GSK Recent Developments/Updates
Table 38.TerSeraTherapeutics Basic Information, Manufacturing Base and Competitors
Table 39.TerSeraTherapeutics Major Business
Table 40.TerSeraTherapeutics Marine Derived Drugs Product and Services
Table 41.TerSeraTherapeutics Marine Derived Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42.TerSeraTherapeutics Recent Developments/Updates
Table 43.Teva Basic Information, Manufacturing Base and Competitors
Table 44.Teva Major Business
Table 45.Teva Marine Derived Drugs Product and Services
Table 46.Teva Marine Derived Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47.Teva Recent Developments/Updates
Table 48. Global Marine Derived Drugs Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 49. Global Marine Derived Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
Table 50. Global Marine Derived Drugs Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 51. Market Position of Manufacturers in Marine Derived Drugs, (Tier 1,Tier 2, andTier 3), Based on Revenue in 2023
Table 52. Head Office and Marine Derived Drugs Production Site of Key Manufacturer
Table 53. Marine Derived Drugs Market: Company ProductTypeFootprint
Table 54. Marine Derived Drugs Market: Company Product ApplicationFootprint
Table 55. Marine Derived Drugs New Market Entrants and Barriers to Market Entry
Table 56. Marine Derived Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Marine Derived Drugs Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
Table 58. Global Marine Derived Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 59. Global Marine Derived Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 60. Global Marine Derived Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 61. Global Marine Derived Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 62. Global Marine Derived Drugs Average Price by Region (2019-2024) & (USD/Unit)
Table 63. Global Marine Derived Drugs Average Price by Region (2025-2030) & (USD/Unit)
Table 64. Global Marine Derived Drugs Sales Quantity byType (2019-2024) & (K Units)
Table 65. Global Marine Derived Drugs Sales Quantity byType (2025-2030) & (K Units)
Table 66. Global Marine Derived Drugs Consumption Value byType (2019-2024) & (USD Million)
Table 67. Global Marine Derived Drugs Consumption Value byType (2025-2030) & (USD Million)
Table 68. Global Marine Derived Drugs Average Price byType (2019-2024) & (USD/Unit)
Table 69. Global Marine Derived Drugs Average Price byType (2025-2030) & (USD/Unit)
Table 70. Global Marine Derived Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 71. Global Marine Derived Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 72. Global Marine Derived Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 73. Global Marine Derived Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 74. Global Marine Derived Drugs Average Price by Application (2019-2024) & (USD/Unit)
Table 75. Global Marine Derived Drugs Average Price by Application (2025-2030) & (USD/Unit)
Table 76. North America Marine Derived Drugs Sales Quantity byType (2019-2024) & (K Units)
Table 77. North America Marine Derived Drugs Sales Quantity byType (2025-2030) & (K Units)
Table 78. North America Marine Derived Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 79. North America Marine Derived Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 80. North America Marine Derived Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 81. North America Marine Derived Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 82. North America Marine Derived Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 83. North America Marine Derived Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 84. Europe Marine Derived Drugs Sales Quantity byType (2019-2024) & (K Units)
Table 85. Europe Marine Derived Drugs Sales Quantity byType (2025-2030) & (K Units)
Table 86. Europe Marine Derived Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 87. Europe Marine Derived Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 88. Europe Marine Derived Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 89. Europe Marine Derived Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 90. Europe Marine Derived Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 91. Europe Marine Derived Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 92. Asia-Pacific Marine Derived Drugs Sales Quantity byType (2019-2024) & (K Units)
Table 93. Asia-Pacific Marine Derived Drugs Sales Quantity byType (2025-2030) & (K Units)
Table 94. Asia-Pacific Marine Derived Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 95. Asia-Pacific Marine Derived Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 96. Asia-Pacific Marine Derived Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 97. Asia-Pacific Marine Derived Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 98. Asia-Pacific Marine Derived Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 99. Asia-Pacific Marine Derived Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 100. South America Marine Derived Drugs Sales Quantity byType (2019-2024) & (K Units)
Table 101. South America Marine Derived Drugs Sales Quantity byType (2025-2030) & (K Units)
Table 102. South America Marine Derived Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 103. South America Marine Derived Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 104. South America Marine Derived Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 105. South America Marine Derived Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 106. South America Marine Derived Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 107. South America Marine Derived Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 108. Middle East & Africa Marine Derived Drugs Sales Quantity byType (2019-2024) & (K Units)
Table 109. Middle East & Africa Marine Derived Drugs Sales Quantity byType (2025-2030) & (K Units)
Table 110. Middle East & Africa Marine Derived Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 111. Middle East & Africa Marine Derived Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 112. Middle East & Africa Marine Derived Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 113. Middle East & Africa Marine Derived Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 114. Middle East & Africa Marine Derived Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 115. Middle East & Africa Marine Derived Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 116. Marine Derived Drugs Raw Material
Table 117. Key Manufacturers of Marine Derived Drugs Raw Materials
Table 118. Marine Derived DrugsTypical Distributors
Table 119. Marine Derived DrugsTypical Customers
LIST OFFIGURES
Figure 1. Marine Derived Drugs Picture
Figure 2. Global Marine Derived Drugs Revenue byType, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Marine Derived Drugs Revenue Market Share byType in 2023
Figure 4. Mollusk Examples
Figure 5. Sponge Examples
Figure 6.Tunicate Examples
Figure 7.Fish Examples
Figure 8. Others Examples
Figure 9. Global Marine Derived Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 10. Global Marine Derived Drugs Revenue Market Share by Application in 2023
Figure 11. Antitumor Drugs Examples
Figure 12. Anti-Cardiovascular Drugs Examples
Figure 13. Others Examples
Figure 14. Global Marine Derived Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Marine Derived Drugs Consumption Value andForecast (2019-2030) & (USD Million)
Figure 16. Global Marine Derived Drugs Sales Quantity (2019-2030) & (K Units)
Figure 17. Global Marine Derived Drugs Price (2019-2030) & (USD/Unit)
Figure 18. Global Marine Derived Drugs Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Marine Derived Drugs Revenue Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Marine Derived Drugs by Manufacturer Sales ($MM) and Market Share (%): 2023
Figure 21.Top 3 Marine Derived Drugs Manufacturer (Revenue) Market Share in 2023
Figure 22.Top 6 Marine Derived Drugs Manufacturer (Revenue) Market Share in 2023
Figure 23. Global Marine Derived Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Marine Derived Drugs Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Marine Derived Drugs Sales Quantity Market Share byType (2019-2030)
Figure 31. Global Marine Derived Drugs Consumption Value Market Share byType (2019-2030)
Figure 32. Global Marine Derived Drugs Average Price byType (2019-2030) & (USD/Unit)
Figure 33. Global Marine Derived Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Marine Derived Drugs Revenue Market Share by Application (2019-2030)
Figure 35. Global Marine Derived Drugs Average Price by Application (2019-2030) & (USD/Unit)
Figure 36. North America Marine Derived Drugs Sales Quantity Market Share byType (2019-2030)
Figure 37. North America Marine Derived Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Marine Derived Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Marine Derived Drugs Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 41. Canada Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 42. Mexico Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 43. Europe Marine Derived Drugs Sales Quantity Market Share byType (2019-2030)
Figure 44. Europe Marine Derived Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Marine Derived Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Marine Derived Drugs Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 48.France Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 49. United Kingdom Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 50. Russia Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 51. Italy Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Marine Derived Drugs Sales Quantity Market Share byType (2019-2030)
Figure 53. Asia-Pacific Marine Derived Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Marine Derived Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Marine Derived Drugs Consumption Value Market Share by Region (2019-2030)
Figure 56. China Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 57. Japan Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 58. South Korea Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 59. India Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 60. Southeast Asia Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 61. Australia Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 62. South America Marine Derived Drugs Sales Quantity Market Share byType (2019-2030)
Figure 63. South America Marine Derived Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Marine Derived Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Marine Derived Drugs Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 67. Argentina Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Marine Derived Drugs Sales Quantity Market Share byType (2019-2030)
Figure 69. Middle East & Africa Marine Derived Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Marine Derived Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 71. Middle East & Africa Marine Derived Drugs Consumption Value Market Share by Country (2019-2030)
Figure 72.Turkey Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 73. Egypt Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 75. South Africa Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 76. Marine Derived Drugs Market Drivers
Figure 77. Marine Derived Drugs Market Restraints
Figure 78. Marine Derived Drugs MarketTrends
Figure 79. PortersFiveForces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Marine Derived Drugs in 2023
Figure 81. Manufacturing Process Analysis of Marine Derived Drugs
Figure 82. Marine Derived Drugs Industrial Chain
Figure 83. Sales Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Marine Derived Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Mollusk
1.3.3 Sponge
1.3.4 Tunicate
1.3.5 Fish
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Marine Derived Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Antitumor Drugs
1.4.3 Anti-Cardiovascular Drugs
1.4.4 Others
1.5 Global Marine Derived Drugs Market Size & Forecast
1.5.1 Global Marine Derived Drugs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Marine Derived Drugs Sales Quantity (2019-2030)
1.5.3 Global Marine Derived Drugs Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Seattle Genetics
2.1.1 Seattle Genetics Details
2.1.2 Seattle Genetics Major Business
2.1.3 Seattle Genetics Marine Derived Drugs Product and Services
2.1.4 Seattle Genetics Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Seattle Genetics Recent Developments/Updates
2.2 Eisai Co
2.2.1 Eisai Co Details
2.2.2 Eisai Co Major Business
2.2.3 Eisai Co Marine Derived Drugs Product and Services
2.2.4 Eisai Co Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Eisai Co Recent Developments/Updates
2.3 Tekada
2.3.1 Tekada Details
2.3.2 Tekada Major Business
2.3.3 Tekada Marine Derived Drugs Product and Services
2.3.4 Tekada Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Tekada Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Marine Derived Drugs Product and Services
2.4.4 Pfizer Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Pfizer Recent Developments/Updates
2.5 Pharma Mar
2.5.1 Pharma Mar Details
2.5.2 Pharma Mar Major Business
2.5.3 Pharma Mar Marine Derived Drugs Product and Services
2.5.4 Pharma Mar Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Pharma Mar Recent Developments/Updates
2.6 Johnson and Johnson
2.6.1 Johnson and Johnson Details
2.6.2 Johnson and Johnson Major Business
2.6.3 Johnson and Johnson Marine Derived Drugs Product and Services
2.6.4 Johnson and Johnson Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Johnson and Johnson Recent Developments/Updates
2.7 GSK
2.7.1 GSK Details
2.7.2 GSK Major Business
2.7.3 GSK Marine Derived Drugs Product and Services
2.7.4 GSK Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 GSK Recent Developments/Updates
2.8 TerSera Therapeutics
2.8.1 TerSera Therapeutics Details
2.8.2 TerSera Therapeutics Major Business
2.8.3 TerSera Therapeutics Marine Derived Drugs Product and Services
2.8.4 TerSera Therapeutics Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 TerSera Therapeutics Recent Developments/Updates
2.9 Teva
2.9.1 Teva Details
2.9.2 Teva Major Business
2.9.3 Teva Marine Derived Drugs Product and Services
2.9.4 Teva Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Teva Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MARINE DERIVED DRUGS BY MANUFACTURER
3.1 Global Marine Derived Drugs Sales Quantity by Manufacturer (2019-2024)
3.2 Global Marine Derived Drugs Revenue by Manufacturer (2019-2024)
3.3 Global Marine Derived Drugs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Marine Derived Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Marine Derived Drugs Manufacturer Market Share in 2023
3.4.3 Top 6 Marine Derived Drugs Manufacturer Market Share in 2023
3.5 Marine Derived Drugs Market: Overall Company Footprint Analysis
3.5.1 Marine Derived Drugs Market: Region Footprint
3.5.2 Marine Derived Drugs Market: Company Product Type Footprint
3.5.3 Marine Derived Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Marine Derived Drugs Market Size by Region
4.1.1 Global Marine Derived Drugs Sales Quantity by Region (2019-2030)
4.1.2 Global Marine Derived Drugs Consumption Value by Region (2019-2030)
4.1.3 Global Marine Derived Drugs Average Price by Region (2019-2030)
4.2 North America Marine Derived Drugs Consumption Value (2019-2030)
4.3 Europe Marine Derived Drugs Consumption Value (2019-2030)
4.4 Asia-Pacific Marine Derived Drugs Consumption Value (2019-2030)
4.5 South America Marine Derived Drugs Consumption Value (2019-2030)
4.6 Middle East & Africa Marine Derived Drugs Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Marine Derived Drugs Sales Quantity by Type (2019-2030)
5.2 Global Marine Derived Drugs Consumption Value by Type (2019-2030)
5.3 Global Marine Derived Drugs Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Marine Derived Drugs Sales Quantity by Application (2019-2030)
6.2 Global Marine Derived Drugs Consumption Value by Application (2019-2030)
6.3 Global Marine Derived Drugs Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Marine Derived Drugs Sales Quantity by Type (2019-2030)
7.2 North America Marine Derived Drugs Sales Quantity by Application (2019-2030)
7.3 North America Marine Derived Drugs Market Size by Country
7.3.1 North America Marine Derived Drugs Sales Quantity by Country (2019-2030)
7.3.2 North America Marine Derived Drugs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Marine Derived Drugs Sales Quantity by Type (2019-2030)
8.2 Europe Marine Derived Drugs Sales Quantity by Application (2019-2030)
8.3 Europe Marine Derived Drugs Market Size by Country
8.3.1 Europe Marine Derived Drugs Sales Quantity by Country (2019-2030)
8.3.2 Europe Marine Derived Drugs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Marine Derived Drugs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Marine Derived Drugs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Marine Derived Drugs Market Size by Region
9.3.1 Asia-Pacific Marine Derived Drugs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Marine Derived Drugs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 South Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Marine Derived Drugs Sales Quantity by Type (2019-2030)
10.2 South America Marine Derived Drugs Sales Quantity by Application (2019-2030)
10.3 South America Marine Derived Drugs Market Size by Country
10.3.1 South America Marine Derived Drugs Sales Quantity by Country (2019-2030)
10.3.2 South America Marine Derived Drugs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Marine Derived Drugs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Marine Derived Drugs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Marine Derived Drugs Market Size by Country
11.3.1 Middle East & Africa Marine Derived Drugs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Marine Derived Drugs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Marine Derived Drugs Market Drivers
12.2 Marine Derived Drugs Market Restraints
12.3 Marine Derived Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Marine Derived Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Marine Derived Drugs
13.3 Marine Derived Drugs Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Marine Derived Drugs Typical Distributors
14.3 Marine Derived Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OFTABLES
Table 1. Global Marine Derived Drugs Consumption Value byType, (USD Million), 2019 & 2023 & 2030
Table 2. Global Marine Derived Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Seattle Genetics Basic Information, Manufacturing Base and Competitors
Table 4. Seattle Genetics Major Business
Table 5. Seattle Genetics Marine Derived Drugs Product and Services
Table 6. Seattle Genetics Marine Derived Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Seattle Genetics Recent Developments/Updates
Table 8. Eisai Co Basic Information, Manufacturing Base and Competitors
Table 9. Eisai Co Major Business
Table 10. Eisai Co Marine Derived Drugs Product and Services
Table 11. Eisai Co Marine Derived Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Eisai Co Recent Developments/Updates
Table 13.Tekada Basic Information, Manufacturing Base and Competitors
Table 14.Tekada Major Business
Table 15.Tekada Marine Derived Drugs Product and Services
Table 16.Tekada Marine Derived Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17.Tekada Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Marine Derived Drugs Product and Services
Table 21. Pfizer Marine Derived Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Pfizer Recent Developments/Updates
Table 23. Pharma Mar Basic Information, Manufacturing Base and Competitors
Table 24. Pharma Mar Major Business
Table 25. Pharma Mar Marine Derived Drugs Product and Services
Table 26. Pharma Mar Marine Derived Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Pharma Mar Recent Developments/Updates
Table 28. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 29. Johnson and Johnson Major Business
Table 30. Johnson and Johnson Marine Derived Drugs Product and Services
Table 31. Johnson and Johnson Marine Derived Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Johnson and Johnson Recent Developments/Updates
Table 33. GSK Basic Information, Manufacturing Base and Competitors
Table 34. GSK Major Business
Table 35. GSK Marine Derived Drugs Product and Services
Table 36. GSK Marine Derived Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. GSK Recent Developments/Updates
Table 38.TerSeraTherapeutics Basic Information, Manufacturing Base and Competitors
Table 39.TerSeraTherapeutics Major Business
Table 40.TerSeraTherapeutics Marine Derived Drugs Product and Services
Table 41.TerSeraTherapeutics Marine Derived Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42.TerSeraTherapeutics Recent Developments/Updates
Table 43.Teva Basic Information, Manufacturing Base and Competitors
Table 44.Teva Major Business
Table 45.Teva Marine Derived Drugs Product and Services
Table 46.Teva Marine Derived Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47.Teva Recent Developments/Updates
Table 48. Global Marine Derived Drugs Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 49. Global Marine Derived Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
Table 50. Global Marine Derived Drugs Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 51. Market Position of Manufacturers in Marine Derived Drugs, (Tier 1,Tier 2, andTier 3), Based on Revenue in 2023
Table 52. Head Office and Marine Derived Drugs Production Site of Key Manufacturer
Table 53. Marine Derived Drugs Market: Company ProductTypeFootprint
Table 54. Marine Derived Drugs Market: Company Product ApplicationFootprint
Table 55. Marine Derived Drugs New Market Entrants and Barriers to Market Entry
Table 56. Marine Derived Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Marine Derived Drugs Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
Table 58. Global Marine Derived Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 59. Global Marine Derived Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 60. Global Marine Derived Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 61. Global Marine Derived Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 62. Global Marine Derived Drugs Average Price by Region (2019-2024) & (USD/Unit)
Table 63. Global Marine Derived Drugs Average Price by Region (2025-2030) & (USD/Unit)
Table 64. Global Marine Derived Drugs Sales Quantity byType (2019-2024) & (K Units)
Table 65. Global Marine Derived Drugs Sales Quantity byType (2025-2030) & (K Units)
Table 66. Global Marine Derived Drugs Consumption Value byType (2019-2024) & (USD Million)
Table 67. Global Marine Derived Drugs Consumption Value byType (2025-2030) & (USD Million)
Table 68. Global Marine Derived Drugs Average Price byType (2019-2024) & (USD/Unit)
Table 69. Global Marine Derived Drugs Average Price byType (2025-2030) & (USD/Unit)
Table 70. Global Marine Derived Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 71. Global Marine Derived Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 72. Global Marine Derived Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 73. Global Marine Derived Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 74. Global Marine Derived Drugs Average Price by Application (2019-2024) & (USD/Unit)
Table 75. Global Marine Derived Drugs Average Price by Application (2025-2030) & (USD/Unit)
Table 76. North America Marine Derived Drugs Sales Quantity byType (2019-2024) & (K Units)
Table 77. North America Marine Derived Drugs Sales Quantity byType (2025-2030) & (K Units)
Table 78. North America Marine Derived Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 79. North America Marine Derived Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 80. North America Marine Derived Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 81. North America Marine Derived Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 82. North America Marine Derived Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 83. North America Marine Derived Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 84. Europe Marine Derived Drugs Sales Quantity byType (2019-2024) & (K Units)
Table 85. Europe Marine Derived Drugs Sales Quantity byType (2025-2030) & (K Units)
Table 86. Europe Marine Derived Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 87. Europe Marine Derived Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 88. Europe Marine Derived Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 89. Europe Marine Derived Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 90. Europe Marine Derived Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 91. Europe Marine Derived Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 92. Asia-Pacific Marine Derived Drugs Sales Quantity byType (2019-2024) & (K Units)
Table 93. Asia-Pacific Marine Derived Drugs Sales Quantity byType (2025-2030) & (K Units)
Table 94. Asia-Pacific Marine Derived Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 95. Asia-Pacific Marine Derived Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 96. Asia-Pacific Marine Derived Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 97. Asia-Pacific Marine Derived Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 98. Asia-Pacific Marine Derived Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 99. Asia-Pacific Marine Derived Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 100. South America Marine Derived Drugs Sales Quantity byType (2019-2024) & (K Units)
Table 101. South America Marine Derived Drugs Sales Quantity byType (2025-2030) & (K Units)
Table 102. South America Marine Derived Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 103. South America Marine Derived Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 104. South America Marine Derived Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 105. South America Marine Derived Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 106. South America Marine Derived Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 107. South America Marine Derived Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 108. Middle East & Africa Marine Derived Drugs Sales Quantity byType (2019-2024) & (K Units)
Table 109. Middle East & Africa Marine Derived Drugs Sales Quantity byType (2025-2030) & (K Units)
Table 110. Middle East & Africa Marine Derived Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 111. Middle East & Africa Marine Derived Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 112. Middle East & Africa Marine Derived Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 113. Middle East & Africa Marine Derived Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 114. Middle East & Africa Marine Derived Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 115. Middle East & Africa Marine Derived Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 116. Marine Derived Drugs Raw Material
Table 117. Key Manufacturers of Marine Derived Drugs Raw Materials
Table 118. Marine Derived DrugsTypical Distributors
Table 119. Marine Derived DrugsTypical Customers
LIST OFFIGURES
Figure 1. Marine Derived Drugs Picture
Figure 2. Global Marine Derived Drugs Revenue byType, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Marine Derived Drugs Revenue Market Share byType in 2023
Figure 4. Mollusk Examples
Figure 5. Sponge Examples
Figure 6.Tunicate Examples
Figure 7.Fish Examples
Figure 8. Others Examples
Figure 9. Global Marine Derived Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 10. Global Marine Derived Drugs Revenue Market Share by Application in 2023
Figure 11. Antitumor Drugs Examples
Figure 12. Anti-Cardiovascular Drugs Examples
Figure 13. Others Examples
Figure 14. Global Marine Derived Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Marine Derived Drugs Consumption Value andForecast (2019-2030) & (USD Million)
Figure 16. Global Marine Derived Drugs Sales Quantity (2019-2030) & (K Units)
Figure 17. Global Marine Derived Drugs Price (2019-2030) & (USD/Unit)
Figure 18. Global Marine Derived Drugs Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Marine Derived Drugs Revenue Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Marine Derived Drugs by Manufacturer Sales ($MM) and Market Share (%): 2023
Figure 21.Top 3 Marine Derived Drugs Manufacturer (Revenue) Market Share in 2023
Figure 22.Top 6 Marine Derived Drugs Manufacturer (Revenue) Market Share in 2023
Figure 23. Global Marine Derived Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Marine Derived Drugs Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Marine Derived Drugs Sales Quantity Market Share byType (2019-2030)
Figure 31. Global Marine Derived Drugs Consumption Value Market Share byType (2019-2030)
Figure 32. Global Marine Derived Drugs Average Price byType (2019-2030) & (USD/Unit)
Figure 33. Global Marine Derived Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Marine Derived Drugs Revenue Market Share by Application (2019-2030)
Figure 35. Global Marine Derived Drugs Average Price by Application (2019-2030) & (USD/Unit)
Figure 36. North America Marine Derived Drugs Sales Quantity Market Share byType (2019-2030)
Figure 37. North America Marine Derived Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Marine Derived Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Marine Derived Drugs Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 41. Canada Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 42. Mexico Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 43. Europe Marine Derived Drugs Sales Quantity Market Share byType (2019-2030)
Figure 44. Europe Marine Derived Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Marine Derived Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Marine Derived Drugs Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 48.France Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 49. United Kingdom Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 50. Russia Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 51. Italy Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Marine Derived Drugs Sales Quantity Market Share byType (2019-2030)
Figure 53. Asia-Pacific Marine Derived Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Marine Derived Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Marine Derived Drugs Consumption Value Market Share by Region (2019-2030)
Figure 56. China Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 57. Japan Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 58. South Korea Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 59. India Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 60. Southeast Asia Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 61. Australia Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 62. South America Marine Derived Drugs Sales Quantity Market Share byType (2019-2030)
Figure 63. South America Marine Derived Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Marine Derived Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Marine Derived Drugs Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 67. Argentina Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Marine Derived Drugs Sales Quantity Market Share byType (2019-2030)
Figure 69. Middle East & Africa Marine Derived Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Marine Derived Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 71. Middle East & Africa Marine Derived Drugs Consumption Value Market Share by Country (2019-2030)
Figure 72.Turkey Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 73. Egypt Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 75. South Africa Marine Derived Drugs Consumption Value (2019-2030) & (USD Million)
Figure 76. Marine Derived Drugs Market Drivers
Figure 77. Marine Derived Drugs Market Restraints
Figure 78. Marine Derived Drugs MarketTrends
Figure 79. PortersFiveForces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Marine Derived Drugs in 2023
Figure 81. Manufacturing Process Analysis of Marine Derived Drugs
Figure 82. Marine Derived Drugs Industrial Chain
Figure 83. Sales Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
